ACADIA PHARMACEUTICALS INC
SEC 4 · Filed
0001996325-26-000002Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Mar 6, 2026
Grant, award or other acquisition by Garner Thomas
- Security
- Restricted Stock Units
- Shares
-
28,493
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-03-06",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F2": "Each restricted stock unit represents a contingent right to receive one share of Issuer\u0027s common stock.",
"F3": "The restricted stock units vest in four equal annual installments beginning March 6, 2027."
},
"owners": [
{
"cik": "0001996325",
"name": "Garner Thomas",
"roles": [
"officer"
],
"title": "EVP, Chief Commercial Officer"
}
],
"ownership": "D",
"post_shares": "28493",
"price": "0",
"row": 2,
"rule_10b5_1": "0",
"security": "Restricted Stock Units",
"shares": "28493",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "28493"
}Insider transactionsEvent date Mar 6, 2026
Grant, award or other acquisition by Garner Thomas
- Security
- Stock Option (Right to Buy)
- Shares
-
97,947
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-03-06",
"direction": "A",
"exercise_price": "22.16",
"expiration": "2036-03-05",
"footnotes": {
"F1": "25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."
},
"owners": [
{
"cik": "0001996325",
"name": "Garner Thomas",
"roles": [
"officer"
],
"title": "EVP, Chief Commercial Officer"
}
],
"ownership": "D",
"post_shares": "97947",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Stock Option (Right to Buy)",
"shares": "97947",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "97947"
}